About NIHR Biomedical Research Units
The NIHR established sixteen Biomedical Research Units in 2008 with four years of funding to undertake translational clinical research in priority areas of high disease burden and clinical need that were under represented.
In 2011 a new competition was launched to select Biomedical Research Units for the next five year period starting 1 April 2012. As a results of the 2011 competition, the NIHR selected 20 new Biomedical Research Units, each addressing a priority area of high disease burden and clinical need.
Each NIHR Biomedical Research Unit is a partnership between an NHS Trust and a university, enabling some of our best health researchers and clinicians to work together to develop new treatments for the benefit of patients. The NIHR Biomedical Research Units:
- Drive innovation in the prevention, diagnosis and treatment of ill-health
- Translate advances in medical research into benefits for patients
- Provide a key component of the NHS contribution to our nation's international competitiveness by building on the best research leaders and their teams and enabling their host institutions to achieve or further develop critical mass in a priority research area.
The amount awarded to each Biomedical Research Unit is determined by the scale and nature of the research activity that it conducts and the anticipated impact of that activity. The awards have been made to the NHS partner, and can only be used to support the recurrent costs of patient focused research.
Further information about NIHR Biomedical Research Units can be found on the NIHR website.